We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Illinois Tool Works
ITW
$82.6B
| $411K | 0.01% |
+5,051
| New | +$409K |
|
|
PRMW
602
PUT
DELISTED
Primo Water Corporation
PRMW
| $408K | 0.01% |
+48,100
| New | +$387K |
|
|
PRMW
603
DELISTED
Primo Water Corporation
PRMW
| $407K | 0.01% |
+47,932
| New | +$386K |
|
604
Edgewell Personal Care
EPC
$1.25B
| $406K | 0.01% |
5,436
-96,718
| -95% | -$7.07M |
|
605
Entergy
ETR
$50.2B
| $405K | 0.01% |
+12,096
| New | +$382K |
|
606
Arrow Electronics
ARW
$11.1B
| $403K | 0.01% |
6,776
-7,457
| -52% | -$406K |
|
607
Tyson Foods
TSN
$20.4B
| $402K | 0.01% |
9,130
-40,989
| -82% | -$1.55M |
|
|
BIG
608
DELISTED
Big Lots, Inc.
BIG
| $398K | 0.01% |
+10,488
| New | +$323K |
|
|
PCP
609
DELISTED
PRECISION CASTPARTS CORP
PCP
| $397K | 0.01% |
1,568
-4,844
| -76% | -$1.25M |
|
610
New York Times
NYT
$12.1B
| $396K | 0.01% |
23,093
-12,623
| -35% | -$195K |
|
611
Ubiquiti
UI
$33.7B
| $396K | 0.01% |
+8,708
| New | +$408K |
|
612
Avnet
AVT
$7.29B
| $390K | 0.01% |
8,366
-7,605
| -48% | -$326K |
|
613
Autodesk
ADSK
$49.5B
| $389K | 0.01% |
+7,905
| New | +$410K |
|
614
HF Sinclair
DINO
$16.3B
| $386K | 0.01% |
8,096
-92,469
| -92% | -$4.37M |
|
615
Newell Brands
NWL
$2.38B
| $386K | 0.01% |
12,899
+5,412
| +72% | +$168K |
|
|
CBST
616
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $386K | 0.01% |
5,272
-9,928
| -65% | -$740K |
|
617
Assured Guaranty
AGO
$3.66B
| $382K | 0.01% |
+15,085
| New | +$357K |
|
618
PNC Financial Services
PNC
$99.7B
| $381K | 0.01% |
4,374
-20,906
| -83% | -$1.71M |
|
|
WWE
619
DELISTED
World Wrestling Entertainment
WWE
| $381K | 0.01% |
+13,175
| New | +$314K |
|
|
WUBA
620
DELISTED
58.com Inc
WUBA
| $377K | 0.01% |
+9,026
| New | +$381K |
|
621
DaVita
DVA
$15.4B
| $376K | 0.01% |
5,451
-142,168
| -96% | -$9.45M |
|
622
KLA
KLAC
$239B
| $376K | 0.01% |
+54,370
| New | +$352K |
|
|
ULTI
623
DELISTED
Ultimate Software Group Inc
ULTI
| $375K | 0.01% |
+2,736
| New | +$429K |
|
|
DNY
624
DELISTED
DONNELLEY R R & SONS CO
DNY
| $372K | 0.01% |
20,757
-7,514
| -27% | -$135K |
|
625
ManpowerGroup
MAN
$2.44B
| $366K | 0.01% |
4,632
-5,068
| -52% | -$401K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.